CRYSTAL HEADY: Open Payments
NPI 1437553724 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,113 in 55 payments from 13 companies in 2025. Trend: 2023 $1,652 · 2024 $1,107 · 2025 $1,113
Food & beverage: $1,113
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $287 |
| Actelion Pharmaceuticals US, Inc. | 4 | $147 |
| HARMONY BIOSCIENCES LLC | 5 | $144 |
| Baxter Healthcare | 8 | $142 |
| Insmed, Inc. | 6 | $111 |
| Amgen Inc. | 3 | $58 |
| United Therapeutics Corporation | 3 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| Viatris Specialty LLC | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
Products named: NUCALA, UPTRAVI, WAKIX, Hillrom - Vest System Model 105 Home Care, Arikayce, TEZSPIRE, TRELEGY ELLIPTA, DUPIXENT.
Industry payments across KY — which companies pay providers there.
